Delivery Order SPE2DB20D3103-SPE2DB25FP5N7
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Capecitabine 500 mg tablets, a medication used in the treatment of certain types of cancer. The contract has a firm fixed price of $1,761.90 and a completion date of November 19, 2024. The award is not designated as a set-aside contract....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,575.44 firm fixed-price delivery order is for the supply of 4,566,609,647 tablets of the drug Capecitabine 500 mg. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,852.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 4,565,070,201 Capecitabine 500 mg tablets, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,115.50 fixed-price contract is for the supply of 120 tablets of the medication Capecitabine 500 mg. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- This federal contract award is for the pharmaceutical product Capecitabine 500 mg Tablet, which was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,927.38, is a Delivery Order type contract with a Firm Fixed Price pricing structure. The ultimate completion date is January 14, 2025, and the award was made on January 13, 2025. The contract was awarded by the Defense Logistics...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,761.90 award is for the supply of 4563170212 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, with a completion date of December 26, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp has previously received numerous DLA contract awards...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FERP1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,673.12, is a Firm Fixed Price Delivery Order to supply the government with 4564584264 ! CAPECITABINE 500 MG TABLET 120S. The contract has an ultimate completion date of May 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is a delivery order valued at $8,071.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100mg doses of the chemotherapy drug paclitaxel, a common cancer treatment medication. The award has a firm fixed price and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $22,158.12 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Dasatinib 50 mg tablets, a medication used to treat certain types of cancer. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA to provide a...
- This federal contract award, valued at $28,692.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5N7Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,389.60 firm fixed price delivery order is for the supply of Capecitabine 500 mg tablets, a medication used to treat certain types of cancer. The award is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 7/17/25 |